Protective efficacy of recombinant proteins adenylate kinase, nucleoside diphosphate kinase, and heat-shock protein 70 against Mycobacterium tuberculosis infection in mice

Seung Heon Lee, Eun Gae Lee, Su Yeon Kim, Sang Nae Cho, Young Kil Park, Gill Han Bai

Research output: Contribution to journalArticle

Abstract

Background: Priming and boosting vaccination strategy has been widely explored for new vaccine development against tuberculosis. As an effort to identify other vaccine candidates, this study was initiated to evaluate protective efficacy of adenylate kinase (AK), nucleoside diphosphate kinase (NdK), and heat shock protein 70 (Hsp70) of Mycobacterium tuberculosis. Method: M. tuberculosis genes encoding AK, NdK, and Hsp70 proteins were amplified by PCR and cloned into E. coli expression vector, pQE30. Recombinant AK, NdK, and Hsp70 was purified through Ni-NTA resin. To evaluate immune responses, we performed enzyme-linked immunosorbent assay (ELISA) for IgG isotype and IFN-γ after mice were immunized subcutaneously with recombinant proteins delivered in dimethyl dioctadecylammonium bromide (DDA). Immunized- and control groups were challenged by aerosol with M. tuberculosis. The spleens and lungs of mice were removed aseptically and cultured for CFU of M. tuberculosis. Result: Vaccination with recombinant proteins AK, NdK, and Hsp70 delivered in DDA elicited significant level of antibody and IFN-γ responses to corresponding antigens but no protective immunity comparable to that achieved with Mycobacterium bovis BCG. Conclusion: Recombinant proteins AK, NdK, and Hsp70 do not effectively control growth of M. tuberculosis in mice when immunized with DDA as an adjuvant.

Original languageEnglish
Pages (from-to)142-151
Number of pages10
JournalTuberculosis and Respiratory Diseases
Volume58
Issue number2
Publication statusPublished - 2005 Feb 1
Externally publishedYes

Fingerprint

Nucleoside-Diphosphate Kinase
Adenylate Kinase
Mycobacterium Infections
HSP70 Heat-Shock Proteins
Mycobacterium tuberculosis
Recombinant Proteins
Protein Kinases
Bromides
Mycobacterium bovis
Vaccination
Vaccines
Aerosols
Antibody Formation
Immunity
Tuberculosis
Spleen
Immunoglobulin G
Enzyme-Linked Immunosorbent Assay
Escherichia coli
Antigens

Keywords

  • Adenylate kinase
  • Heat shock protein70
  • Mycobacterium tuberculosis
  • Nucleoside diphosphate kinase
  • Protective efficacy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Protective efficacy of recombinant proteins adenylate kinase, nucleoside diphosphate kinase, and heat-shock protein 70 against Mycobacterium tuberculosis infection in mice. / Lee, Seung Heon; Lee, Eun Gae; Kim, Su Yeon; Cho, Sang Nae; Park, Young Kil; Bai, Gill Han.

In: Tuberculosis and Respiratory Diseases, Vol. 58, No. 2, 01.02.2005, p. 142-151.

Research output: Contribution to journalArticle

@article{a5906b49ac89453baed23e168e6bf516,
title = "Protective efficacy of recombinant proteins adenylate kinase, nucleoside diphosphate kinase, and heat-shock protein 70 against Mycobacterium tuberculosis infection in mice",
abstract = "Background: Priming and boosting vaccination strategy has been widely explored for new vaccine development against tuberculosis. As an effort to identify other vaccine candidates, this study was initiated to evaluate protective efficacy of adenylate kinase (AK), nucleoside diphosphate kinase (NdK), and heat shock protein 70 (Hsp70) of Mycobacterium tuberculosis. Method: M. tuberculosis genes encoding AK, NdK, and Hsp70 proteins were amplified by PCR and cloned into E. coli expression vector, pQE30. Recombinant AK, NdK, and Hsp70 was purified through Ni-NTA resin. To evaluate immune responses, we performed enzyme-linked immunosorbent assay (ELISA) for IgG isotype and IFN-γ after mice were immunized subcutaneously with recombinant proteins delivered in dimethyl dioctadecylammonium bromide (DDA). Immunized- and control groups were challenged by aerosol with M. tuberculosis. The spleens and lungs of mice were removed aseptically and cultured for CFU of M. tuberculosis. Result: Vaccination with recombinant proteins AK, NdK, and Hsp70 delivered in DDA elicited significant level of antibody and IFN-γ responses to corresponding antigens but no protective immunity comparable to that achieved with Mycobacterium bovis BCG. Conclusion: Recombinant proteins AK, NdK, and Hsp70 do not effectively control growth of M. tuberculosis in mice when immunized with DDA as an adjuvant.",
keywords = "Adenylate kinase, Heat shock protein70, Mycobacterium tuberculosis, Nucleoside diphosphate kinase, Protective efficacy",
author = "Lee, {Seung Heon} and Lee, {Eun Gae} and Kim, {Su Yeon} and Cho, {Sang Nae} and Park, {Young Kil} and Bai, {Gill Han}",
year = "2005",
month = "2",
day = "1",
language = "English",
volume = "58",
pages = "142--151",
journal = "Tuberculosis and Respiratory Diseases",
issn = "1738-3536",
publisher = "The Korean Academy of Tuberculosis and Respiratory Diseases",
number = "2",

}

TY - JOUR

T1 - Protective efficacy of recombinant proteins adenylate kinase, nucleoside diphosphate kinase, and heat-shock protein 70 against Mycobacterium tuberculosis infection in mice

AU - Lee, Seung Heon

AU - Lee, Eun Gae

AU - Kim, Su Yeon

AU - Cho, Sang Nae

AU - Park, Young Kil

AU - Bai, Gill Han

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Background: Priming and boosting vaccination strategy has been widely explored for new vaccine development against tuberculosis. As an effort to identify other vaccine candidates, this study was initiated to evaluate protective efficacy of adenylate kinase (AK), nucleoside diphosphate kinase (NdK), and heat shock protein 70 (Hsp70) of Mycobacterium tuberculosis. Method: M. tuberculosis genes encoding AK, NdK, and Hsp70 proteins were amplified by PCR and cloned into E. coli expression vector, pQE30. Recombinant AK, NdK, and Hsp70 was purified through Ni-NTA resin. To evaluate immune responses, we performed enzyme-linked immunosorbent assay (ELISA) for IgG isotype and IFN-γ after mice were immunized subcutaneously with recombinant proteins delivered in dimethyl dioctadecylammonium bromide (DDA). Immunized- and control groups were challenged by aerosol with M. tuberculosis. The spleens and lungs of mice were removed aseptically and cultured for CFU of M. tuberculosis. Result: Vaccination with recombinant proteins AK, NdK, and Hsp70 delivered in DDA elicited significant level of antibody and IFN-γ responses to corresponding antigens but no protective immunity comparable to that achieved with Mycobacterium bovis BCG. Conclusion: Recombinant proteins AK, NdK, and Hsp70 do not effectively control growth of M. tuberculosis in mice when immunized with DDA as an adjuvant.

AB - Background: Priming and boosting vaccination strategy has been widely explored for new vaccine development against tuberculosis. As an effort to identify other vaccine candidates, this study was initiated to evaluate protective efficacy of adenylate kinase (AK), nucleoside diphosphate kinase (NdK), and heat shock protein 70 (Hsp70) of Mycobacterium tuberculosis. Method: M. tuberculosis genes encoding AK, NdK, and Hsp70 proteins were amplified by PCR and cloned into E. coli expression vector, pQE30. Recombinant AK, NdK, and Hsp70 was purified through Ni-NTA resin. To evaluate immune responses, we performed enzyme-linked immunosorbent assay (ELISA) for IgG isotype and IFN-γ after mice were immunized subcutaneously with recombinant proteins delivered in dimethyl dioctadecylammonium bromide (DDA). Immunized- and control groups were challenged by aerosol with M. tuberculosis. The spleens and lungs of mice were removed aseptically and cultured for CFU of M. tuberculosis. Result: Vaccination with recombinant proteins AK, NdK, and Hsp70 delivered in DDA elicited significant level of antibody and IFN-γ responses to corresponding antigens but no protective immunity comparable to that achieved with Mycobacterium bovis BCG. Conclusion: Recombinant proteins AK, NdK, and Hsp70 do not effectively control growth of M. tuberculosis in mice when immunized with DDA as an adjuvant.

KW - Adenylate kinase

KW - Heat shock protein70

KW - Mycobacterium tuberculosis

KW - Nucleoside diphosphate kinase

KW - Protective efficacy

UR - http://www.scopus.com/inward/record.url?scp=17844409873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844409873&partnerID=8YFLogxK

M3 - Article

VL - 58

SP - 142

EP - 151

JO - Tuberculosis and Respiratory Diseases

JF - Tuberculosis and Respiratory Diseases

SN - 1738-3536

IS - 2

ER -